REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification
ACTIVE_NOT_RECRUITING
Status
Conditions
- Atherosclerotic Cardiovascular Disease
Interventions
- DRUG: Anacetrapib
- DRUG: Placebo anacetrapib
Sponsor
University of Oxford
Collaborators